Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/12/2005CN1681533A Medicinal composition for treating arteriosclerosis
10/12/2005CN1681529A Immunogenic compositions and diagnostic and therapeutic uses thereof
10/12/2005CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
10/12/2005CN1681519A Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient
10/12/2005CN1681518A Combination therapies with L-FMAU for the treatment of hepatitis b virus infection
10/12/2005CN1681517A Peptide boronic acids useful in making salts thereof
10/12/2005CN1681516A Method for preventing or reducing secondary fractures after hip fracture
10/12/2005CN1681515A Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
10/12/2005CN1681513A Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
10/12/2005CN1681512A Treatment of basal ganglia-related movement disorders with 2, 3-benzodiazepines
10/12/2005CN1681511A Combinations of drugs for the treatment of neoplasms
10/12/2005CN1681510A Use of PDE IV inhibitors to treat angiogenesis
10/12/2005CN1681509A Slow release preparation containing larmotriazine
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681507A New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
10/12/2005CN1681506A Use of a quinazoline derivative for treating lower urinary tract symptoms
10/12/2005CN1681505A Combination of a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681500A Topical treatment of skin diseases
10/12/2005CN1681499A Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/12/2005CN1681497A Dispersible tablets for oral administration
10/12/2005CN1681496A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/12/2005CN1681495A Combination therapy for hyperplasia diseases
10/12/2005CN1681494A 4-(3, 5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of I.A. HIV
10/12/2005CN1681493A Taste masked sumatriptan tablets and processes for their preparation
10/12/2005CN1681492A Combinations of atorvastatin and alpha1adrenergic receptor antagonists
10/12/2005CN1681491A Treatment of dyskinesia
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1681489A Combination of chemotherapeutic drugs for increasing antitumor activity
10/12/2005CN1681488A Drug for kidney failure containing oxaluric acid derivative
10/12/2005CN1681487A Compounds, compositions, and methods for employing the same
10/12/2005CN1681486A Pharmaceutical formulations of modafinil
10/12/2005CN1681485A Novel pharmaceutical formulations of modafinil
10/12/2005CN1681484A Orally administrable composition for improving skin quality
10/12/2005CN1681483A Improved oral microcapsule with low-solubility active component
10/12/2005CN1681481A Legemiddel inneholdende vardenafilhydrokloridtrihydrat
10/12/2005CN1681473A Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent
10/12/2005CN1681399A Cereal based food product comprising DHA and/or EPA
10/12/2005CN1681386A Compositions and products containing s-equol, and methods for their making
10/12/2005CN1680568A Microbiological coverting product of curcumenol, use and preparation thereof
10/12/2005CN1680563A Amino alcohol derivatives
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680424A Preparation and use for active saponin
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1680420A Keto-lactones compound, its purposes, preparation method and pharmaceutical compositio
10/12/2005CN1680419A Keto-lactones compound, its purposes, preparation method and pharmaceutical compositio
10/12/2005CN1680418A Keto-lactones compound, its purposes, preparation method and pharmaceutical composition
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680390A Halogenated dihydroartemisine, preparation and use thereof
10/12/2005CN1680384A Norcantharidin platinum complex and its use
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680377A 4-oxo-4, 6, 7, 8-tetrahydro-pyrrolo[1, 2-a]pyrazine-6-carboxamide compounds
10/12/2005CN1680376A Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5- alpha ]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/12/2005CN1680374A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680372A New benzo[b]chromeno-naphthyridin-7-one and pyrano[2', 3':7, 8] quino[2, 3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680370A Epothilones C, and its preparation and use as cell inhibitor
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680365A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680364A Method for producing lipoic acid and dihydrolipoic acid
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680355A Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1680350A Crystalline base of citalopram
10/12/2005CN1680343A New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680341A Valsartan salts
10/12/2005CN1680339A Benzimidazole derivative
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680326A Pharmaceutical compositions and methods for use
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680313A Farnesyl transferase inhibitors
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680304A Lingshui alcohol with anti-cancer activity, its preparation and use
10/12/2005CN1680293A Processes for the production of alpha-difluoromethyl ornithine (dfmo)
10/12/2005CN1680292A Compounds useful as intermediates of 4-aminoquinoline deravative
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680279A Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof
10/12/2005CN1680259A Aspirin-triggered lipid mediators
10/12/2005CN1680252A C60 trans-succinate with biologic activity and its synthesis
10/12/2005CN1680248A Use of 2', 4'-dihydroxy-6'-methoxy-3', 5'-dimethyl chalkone as reversing agent for resistance of multiple tumours drugs
10/12/2005CN1680243A Process for the preparation of non-steroidal glucocorticoid receptor modulators
10/12/2005CN1680238A Preparation and use of compounds i.e., 1, 3-dihydroxy-5-alkyl benzene as inhbitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1680235A Preparation and use of compounds i.e., falcarindiol as inhibitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1679981A Medicine composition for treating beriberi
10/12/2005CN1679962A Pharmaceutical compositions
10/12/2005CN1679958A Implants for administering substances and methods of producing implants
10/12/2005CN1679956A Treatment of androgen-deprivation induced osteoporosis
10/12/2005CN1679955A Compositions for improving drug safety
10/12/2005CN1679954A Compound preparation of calcium antagonist and timishatan for reducing blood pressure and its use
10/12/2005CN1679953A Pharmaceutical composition for regulating lipid concentration
1 ... 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 ... 7860